Lazuline Biotech Profile
Key Indicators
- Authorised Capital ₹ 54.00 Cr
as on 18-06-2024
- Paid Up Capital ₹ 42.14 Cr
as on 18-06-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 71.00 Cr
as on 18-06-2024
- Revenue 180.73%
(FY 2023)
- Profit 23.71%
(FY 2023)
- Ebitda 126.16%
(FY 2023)
- Net Worth -6.06%
(FY 2023)
- Total Assets 3.88%
(FY 2023)
About Lazuline Biotech
The Corporate was formerly known as Tkr Lifesciences Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 54.00 Cr and a paid-up capital of Rs 42.14 Cr.
The company currently has active open charges totaling ₹71.00 Cr.
The Key Managerial Personnel (KMP) at Lazuline Biotech Private Limited India are Palla Sivaiah as COMPANY SECRETARY and Kumar Kandimalla as Ceo. Ramireddy Tummuru, Kumar Kandimalla, and Satya Kandimalla serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PTC118015
- Company No.
118015
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2011
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Shaikpet, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Lazuline Biotech Private Limited offer?
Lazuline Biotech Private Limited offers a wide range of products and services, including Immunization & Vaccination Drugs, Infant Vaccines, Textile, Dyeing & Finishing Chemical, Textile Enzymes.
Who are the key members and board of directors at Lazuline Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palla Sivaiah  | Company Secretary | 26-Mar-2024 | Current |
| Kumar Kandimalla | Managing Director | 22-Apr-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramireddy Tummuru  | Director | 24-Oct-2011 | Current |
| Satya Kandimalla | Director | 21-Jul-2017 | Current |
Financial Performance of Lazuline Biotech.
Lazuline Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 180.73% increase. The company also saw a substantial improvement in profitability, with a 23.71% increase in profit. The company's net worth dipped by a decrease of 6.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lazuline Biotech?
In 2022, Lazuline Biotech had a promoter holding of 68.32% and a public holding of 31.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Riddhi Proven Private LimitedActive 5 years 17 daysKumar Kandimalla and Satya Kandimalla are mutual person
- Knp Projects Private LimitedActive 12 years 2 months
Kumar Kandimalla and Satya Kandimalla are mutual person
- Mcc Consulting Private LimitedActive 9 years 11 months
Kumar Kandimalla and Satya Kandimalla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Nov 2021 | ₹2.90 Cr | Open |
Canara Bank Creation Date: 30 Jun 2021 | ₹12.00 Cr | Open |
Canara Bank Creation Date: 27 Oct 2020 | ₹4.15 Cr | Open |
How Many Employees Work at Lazuline Biotech?
Lazuline Biotech has a workforce of 56 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lazuline Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lazuline Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
